| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |